Getting Pregnant on Wegovy: What the Guidance Says and What to Do Next

Wegovy is not recommended in pregnancy: clinical guidelines advise stopping immediately if you find out you are pregnant while on treatment.
Semaglutide stays in the body for around five weeks after the last dose, so the medicine is present for some time even after you stop the pen.
MHRA guidance advises using effective contraception during treatment and for at least two months after stopping before trying to conceive.
Stopping Wegovy does not end your pregnancy and does not automatically cause harm, but your GP or midwife needs to know as soon as possible so they can support you.

If you discover you are pregnant while taking Wegovy, the clear advice from UK clinical guidance is to stop the medicine immediately and speak to your GP or midwife as soon as possible. Wegovy (semaglutide) is not recommended during pregnancy — not because harm in humans is proven, but because the safety data simply does not exist to say it is safe, and animal studies have raised concerns. The NHS medicines page for semaglutide is unambiguous on this point: do not use it if you are or might be pregnant. What happens next depends on how far along you are, how long you were taking it, and what support you have around you — so getting medical advice quickly matters.

Starting from £29.99/mo

Free 2-minute consultation · Reviewed same day

Start journey
The nume Promise

Order by 12pm.

At your door the next working day.
Free, tracked, plain packaging.

Guaranteed on approved orders

Where are you starting from?

BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.

Check your BMI.

Ten seconds. Private — nothing is stored or shared.

80 kg
170 cm

Your result updates live in the card alongside.

Your result

Your BMI is

which is in the healthy weight range

Start journey

BMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.

Treatment options

Weight loss treatments

The problem

Most weight loss services treat you like a transaction, a checkout, a courier, and you're on your own.

Algorithm approvalsNo real clinicianGeneric dosingHidden feesSlow deliverySilence after checkout

The nume way

We built the opposite: one clinician who knows you, guaranteed care at every step.

24 hrs

clinician review. Free next working day delivery.

How it works

From consultation to your door, properly.

Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.

Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.

Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.

Pregnancy, semaglutide and what the evidence actually tells us

What official UK guidance says about Wegovy and pregnancy

The position in the UK is not ambiguous. Semaglutide is not authorised for use in pregnancy, and both the NHS and the Medicines and Healthcare products Regulatory Agency advise stopping treatment as soon as pregnancy is confirmed. The NHS England overview of weight-management injections addresses this directly: if you become pregnant while on a GLP-1 medicine, discontinue it and contact your maternity team promptly.

This caution comes from the absence of adequate human safety data, combined with findings from animal reproductive studies that showed adverse effects at exposures relevant to therapeutic doses. That does not mean a brief exposure early in pregnancy will cause harm, it means the data to reassure us simply does not exist yet. Regulators take the precautionary approach, which is the right one. If you are wondering whether you can take Wegovy if you are pregnant, your midwife and GP are the people best placed to interpret your individual situation once they know what week you are, how long you were on Wegovy, and your overall health picture.

One practical note worth knowing: semaglutide has a long half-life. After your last weekly injection, the medicine continues to clear from your system over roughly five weeks. So even once you stop, it remains biologically present for a period. This is another reason early disclosure to your maternity team matters, they will want to know the full timeline.

What to do the moment you get a positive test

Stop the injection. Do not take the next scheduled dose. The pen in your fridge door (or wherever you store it) stays there. Contact your GP surgery the same day or the next morning at the latest; if you cannot reach your GP, your midwife team or an NHS 111 call can bridge the gap while you wait for a proper appointment.

When you speak to your doctor, be ready to tell them: the dose you were on, how recently you took your last injection, and how far along you think you are. They will not judge you for having been on weight-loss treatment, and our page covering what happens if you have got pregnant on Wegovy explains why this situation is more common than many people realise, partly because, as explored on our page about Wegovy and fertility, GLP-1 medicines can improve ovulation regularity in people with conditions such as PCOS, sometimes making conception more likely than expected.

Your GP may want to arrange earlier dating scans or additional monitoring. That is standard care, not a sign that something has gone wrong. The priority at this stage is establishing accurate dates and getting you into appropriate maternity care.

Contraception, the wash-out period, and planning ahead

For anyone on Wegovy who is not currently pregnant but wants to conceive in the future, UK guidance is clear about timing. MHRA advice calls for effective contraception throughout treatment. Before trying for a baby, you should stop Wegovy and allow at least two months for the medicine to fully clear before attempting conception. This wash-out period is designed to reduce foetal exposure to semaglutide during the critical early weeks of pregnancy.

If you were already planning to conceive, the right conversation is with your prescriber before you stop contraception, not after a positive test. Our clinical team can help you think through when and how to pause treatment, you can read more about Wegovy and pregnancy planning or explore how becoming pregnant while on Wegovy is handled clinically. Stopping the medicine does not erase the metabolic benefits you have built, many people maintain a meaningful portion of their weight loss for months afterwards, especially when lifestyle habits are in place.

Breastfeeding carries the same caution: semaglutide is not recommended while nursing, because it is not known whether the medicine passes into breast milk or what effect it might have on a feeding infant. A clinician will advise on when it is appropriate to restart treatment after pregnancy and breastfeeding are complete.

Returning to Wegovy after pregnancy

Restarting semaglutide after you have given birth and finished breastfeeding is possible, but it requires a fresh clinical assessment, not just picking up where you left off. The dose schedule starts again from the beginning (the same gradual titration used when treatment is initiated) to give your body time to readjust and to minimise side effects. A lot can change during pregnancy and the postnatal period, so a prescriber will want a current picture of your weight, health, and any new conditions before recommending a path forward, and our dedicated page on Wegovy and being pregnant sets out what that process involves.

If you want to understand your options for weight management after pregnancy, our weight-loss treatment overview covers what is available and how clinical assessment works. When you are ready, speaking to our prescribers is the starting point, every consultation is reviewed by a GPhC-registered Independent Prescriber, and there is no pressure to restart treatment before you feel ready.

Looking to start your weight loss journey?
Take a quick eligibility quiz to explore your options and see how we can support you.
Start free consultation

The people

Meet the team.

Mahommed Zunaid Ayub Patel

Superintendent Pharmacist (GPhC No. 2217101)

Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.

Mostafa Damghani

Clinical Lead (GPhC No. 2231744)

Sets our clinical standards and checks everything we publish against current MHRA guidance.

Shelan Salih

Independent Prescriber (GPhC No. 2084501)

Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.

Rehenaaz Uddin

Independent Prescriber (GPhC No. 2083426)

Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.

Frequently asked questions